SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: 10-K
Document Type: EX-4.1
Date Filed: 2026-04-01
Accession Number: 0001213900-26-037883
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390026037883/ea028351301ex4-1.htm

Chunk 0 of 2
Word Count: 1499
Character Count: 9499

Document Content:

Exhibit 4.1

DESCRIPTION OF THE
REGISTRANT’S SECURITIES

REGISTERED PURSUANT
TO SECTION 12 OF THE

SECURITIES EXCHANGE
ACT OF 1934

The following summary of
the capital stock of Synergy CHC Corp. (the “Company”), does not purport to be complete and is qualified in its entirety by
reference to our Articles of Incorporation, as amended (the “Articles”), and our amended and restated bylaws (the “Bylaws”),
each of which are incorporated by reference as an exhibit to the Annual Report on Form 10-K (the “Annual Report”), of which
this exhibit is a part, and certain provisions of the Nevada Revised Statutes (“NRS”). Unless the context requires otherwise,
all references to the “Company,” “Synergy,” “we,” “our,” and “us” in this
Exhibit refer to Synergy CHC Corp. Capitalized terms used but not defined herein have the meanings set forth in the Annual Report to which
this description is an exhibit.

DESCRIPTION OF SECURITIES

The following summary
of the material terms of our securities and is not intended to be a complete summary of the rights and preferences of such securities.
We urge you to read our Articles and Bylaws in their entirety for a complete description of the rights and preferences of our securities.

General

Our authorized capital
stock consists of 300,000,000 shares of common stock, par value $0.00001 per share (“common stock”). As of March 27,
2026, there were 11,483,926 shares of common stock issued and 11,303,853 shares outstanding, held by approximately 69 stockholders
of record.

Common Stock

Dividend Rights

The holders of outstanding
shares of our common stock are entitled to receive dividends out of funds legally available at the times and in the amounts that our Board
of Directors may determine.

Voting Rights

Each holder of our common
stock is entitled to one vote for each share of common stock held on all matters submitted to a vote of stockholders. Cumulative voting
for the election of directors is not provided for in our articles of incorporation, which means that the holders of a majority of our
shares of common stock voted can elect all of the directors then standing for election.

Preemptive or Similar
Rights

Our common stock is not entitled
to preemptive rights and is not subject to conversion or redemption.

Liquidation Rights

Upon our liquidation, dissolution,
or winding-up, the assets legally available for distribution to our stockholders would be distributable ratably among the holders of our
common stock outstanding at that time after payment of other claims of creditors.

Anti-Takeover Effects
of Certain Provisions of Nevada Law

Effect of Nevada Anti-takeover
Statute. We are subject to Section 78.438 of the Nevada Revised Statutes, an anti-takeover law. In general, Section 78.438 prohibits
a Nevada corporation from engaging in any business combination with any interested stockholder for a period of two years following the
date that the stockholder became an interested stockholder, unless prior to that date, the board of directors of the corporation approved
either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder, or if after the
date that the stockholder becomes an interested stockholder the business combination is approved by the board of directors and by 60%
of the voting power of all disinterested stockholders at either an annual or special meeting of the stockholders of the corporation. Section
78.439 provides that business combinations after the two-year period following the date that the stockholder becomes an interested stockholder
may also be prohibited unless either approved by the corporation’s directors before the stock acquisition, or by a majority of the
disinterested stockholders or unless the price and terms of the transaction meet other criteria set forth in the statute.

Section 78.416 defines “business
combination” to include the following:

●	any merger or consolidation involving the corporation and the interested stockholder or any other corporation which is an affiliate or associate of the interested stockholder;

●	any sale, transfer, pledge or other disposition of the assets of the corporation involving the interested stockholder or any affiliate or associate of the interested stockholder if the assets transferred have a market value equal to 5% or more of all of the assets of the corporation or 5% or more of the value of the outstanding shares of the corporation or represent 10% or more of the earning power of the corporation;

●	subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to an interested stockholder, with a market value of 5% or more of the value of the outstanding shares of the corporation;

●	the adoption of a plan of liquidation proposed by or under any arrangement with the interested stockholder or any affiliate or associate of the interested stockholder;

●	any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of voting shares of securities convertible into voting shares of the corporation beneficially owned by the interested stockholder or any affiliate or associate of the interested stockholder; or

●	the receipt by the interested stockholder or any affiliate or associate of the interested stockholder of the benefit, except proportionately as a stockholder of the corporation, of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation.

In general, Section 78.423
defines an interested stockholder as any entity or person beneficially owning, directly or indirectly, 10% or more of the outstanding
voting stock of the corporation and any entity or person affiliated with or controlling or controlled by any of these entities or persons.

Control Share Acquisitions.
Sections 78.378 through 78.3793 of the Nevada Revised Statutes limit the voting rights of certain acquired shares in a corporation. The
provisions apply to any acquisition of outstanding voting securities of a Nevada corporation that has 200 or more stockholders, at least
100 of which are Nevada residents, and conducts business in Nevada (an “issuing corporation”) resulting in ownership of one
of the following categories of an issuing corporation’s then outstanding voting securities: (i) twenty percent or more but less
than thirty-three percent; (ii) thirty-three percent or more but less than fifty percent; or (iii) fifty percent or more. The securities
acquired in such acquisition are denied voting rights unless a majority of the security holders approve the granting of such voting rights.
Unless an issuing corporation’s articles of incorporation or bylaws then in effect provide otherwise: (i) voting securities acquired
are also redeemable in part or in whole by an issuing corporation at the average price paid for the securities within 30 days if the acquiring
person has not given a timely information statement to an issuing corporation or if the stockholders vote not to grant voting rights to
the acquiring person’s securities, and (ii) if outstanding securities and the security holders grant voting rights to such acquiring
person, then any security holder who voted against granting voting rights to the acquiring person may demand the purchase from an issuing
corporation, for fair value, all or any portion of his securities. These provisions do not apply to acquisitions made pursuant to the
laws of descent and distribution, the enforcement of a judgment, or the satisfaction of a security interest, or made in connection with
certain mergers or reorganizations.

Indemnification of
Directors and Officers

Neither our articles of incorporation,
nor our amended and restated bylaws, prevent us from indemnifying our officers, directors and agents to the extent permitted under the
NRS. NRS Section 78.7502, provides that a corporation may indemnify any director, officer, employee or agent of a corporation against
expenses, including fees, actually and reasonably incurred by him in connection with any defense to the extent that a director, officer,
employee or agent of a corporation has been successful on the merits or otherwise in defense of any action, suit or proceeding referred
to Section 78.7502(1) or 78.7502(2), or in defense of any claim, issue or matter therein.

NRS 78.7502(1) provides that
a corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed
action, suit or proceeding, whether civil, criminal, administrative or investigative, except an action by or in the right of the corporation,
by reason of the fact that he is or was a director, officer, employee or agent of the corporation, or is or was serving at the request
of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise,
against expenses, including attorneys’ fees, judgments, fines and amounts paid in settlement actually and reasonably incurred by
him in connection with the action, suit or proceeding if he: (a) is not liable pursuant to NRS 78.138; or (b) acted in good faith and
in a manner which he reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal
action or proceeding, had no reasonable cause to believe his conduct was unlawful.